BridgeMD
Compares treatment options for Gastric Cancer
Official title "Phase III Randomized Trial Comparing D2 vs D3 Lymphadenectomy With Gastric Cancer Following Neoadjuvant Chemotherapy
ClinicalTrials.gov ID: NCT02139605
What this study is testing
- What it's testing
- Stomach cancer is the second most common cause of cancer-related deaths in India. Curative surgery offers the only chance of improving survival in this cancer.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- ECOG performance status of 0 - 1 in patients deemed fit to undergo surgery at the pre-anaesthetic check
- Histologically proven gastric adenocarcinoma
- No evidence of distant metastases, or locally advanced inoperable disease, as evaluated by computed tomography, chest radiography, ultrasonography...
- Patient able to provide valid informed consent
- Patient completed at least 1 cycle of neoadjuvant chemotherapy
You likely can't join if
- Presence of any 1 of the following:
- Previous or concomitant other cancer
- Primary Oesophageal involvement extending to the stomach
- Distant hepatic / extrahepatic disease discovered on laparotomy
- Gross local disease in the porta precluding a curative resection
- Patient did not consent for the trial
The study team makes the final eligibility decision.
Where it's taking place
- Mumbai, Maharashtra, India
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mumbai, Maharashtra, India. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.